INVESTORS

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Jun 10, 2021
Document Date
Jul 23, 2020
Form Description
An amendment to a 3 filing. Non-EDGAR filing
Filing Group
3,4,5
Company
Protara Therapeutics, Inc.
Issuer
PROTARA THERAPEUTICS, INC.
Filer
Flannelly Barry P

IR Contact

Justine O’Malley 
Vice President, Investor Relations and Communications 
Phone: 646-817-2836
Email: Justine.OMalley@protaratx.com

Scroll to Top